Blood Collection From Heart Failure Patients to Evaluate for Galectin-3 Measurement Differences Using Various Collection Tubes
Completed
- Conditions
- To Measure Galectin-3 in Heart Failure Patients on Commercial Platforms
- Registration Number
- NCT01980862
- Lead Sponsor
- Fujirebio Diagnostics, Inc.
- Brief Summary
Single-site blood collection investigation.
- Detailed Description
45 Heart Failure patients will be recruited. Patients will provide a one-time blood sample specimen collection. Theses samples will be de-identified and provided for measurement of Galectin-3 on commercial platforms.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
- Heart Failure patients New York Heart Association class able to provide (4) collection tube types Subjects > 18 years old All subjects must provide informed consent and associated documentation
Exclusion Criteria
- Subjects that cannot tolerate blood withdrawal of 4 specimens collection tube tubes (approximately 40 mLs)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Obtain 45 matched donor serum and plasma samples sets collected from Heart Failure patients for galectin-3 measurements 6 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Maryland School of Medicine
🇺🇸Baltimore, Maryland, United States